Fambrough Douglas Insider Trades

Insider Trading History

Track insider trading activity for Fambrough Douglas. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Oncorus
Oncorus ONCR
Director
Holding Value $3.15k 25,000 shares
Last Trade
Jun 22, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$37.5k 25,000 shares
$1.50
$0.13
Oncorus
Oncorus ONCR
Director
Holding Value $0 0 shares
Last Trade
Jun 22, 2022 Sale
$22.5k 15,000 shares
$1.50
$0.13
Oncorus
Oncorus ONCR
Director
Holding Value $3.15k 25,000 shares
Last Trade
Jun 22, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$37.5k 25,000 shares
$1.50
$0.13
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Dec 28, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.58M 41,250 shares
$38.22
$38.22
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Dec 28, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$8.85M 231,431 shares
$38.25
$38.22
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Dec 28, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$9.47M 247,700 shares
$38.22
$38.22
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Dec 28, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$7.64M 200,000 shares
$38.22
$38.22
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Dec 28, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$19.3M 505,000 shares
$38.22
$38.22
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Dec 28, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$9.75M 255,000 shares
$38.22
$38.22
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Dec 28, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$8.6M 225,000 shares
$38.22
$38.22
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Dec 28, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$7.31M 191,330 shares
$38.22
$38.22
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Dec 28, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$2.1M 55,055 shares
$38.22
$38.22
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Dec 28, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$9.56M 250,000 shares
$38.22
$38.22
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Dec 28, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$8.6M 225,000 shares
$38.22
$38.22
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
Chief Executive Officer
Holding Value $1.58M 41,250 shares
Last Trade
Dec 15, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$523k 13,750 shares
$38.05
$38.22
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
Chief Executive Officer
Holding Value $9.05M 236,779 shares
Last Trade
Dec 15, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$523k 13,750 shares
$38.05
$38.22
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
Chief Executive Officer
Holding Value $8.85M 231,431 shares
Last Trade
Dec 15, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$203k 5,348 shares
$38.05
$38.22
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
Chief Executive Officer
Holding Value $7.31M 191,330 shares
Last Trade
Dec 10, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.82M 179,865 shares
$37.91
$38.22
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
Chief Executive Officer
Holding Value $8.52M 223,029 shares
Last Trade
Dec 10, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.82M 179,865 shares
$37.91
$38.22
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
President And CEO
Holding Value $1.65M 43,164 shares
Last Trade
Aug 10, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$111k 5,000 shares
$22.10
$38.22

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up